PRA International Plans to Open New BioAnalytical Laboratory
In October of this year, PRA International plans to open their new Bioanalytical Laboratory facility, located in close proximity to PRA's U.S. based Phase I Clinic in Lenexa, Kansas. This facility will be equipped with state-of-the-art LC/MS/MS equipment.
Currently PRA has a Bioanalytical Laboratory facility located in Assen, The Netherlands. This is a GLP-compliant laboratory began operating in the mid 1980's. The facility's analytical capabilities include:
- Equipment for mass spectrometry
- Ultra performance liquid chromatography
- Biomarkers
- Biochemistry & immunochemistry
- Radioisotope analysis
- Handling of biohazard samples
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
